Artivion, Inc. — Earnings Quality Grade F
AORT · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 74 days, change -0 days YoY
AR growth 13.0% vs revenue growth 13.6%
Revenue 13.6%, CFFO 79.3%. Cash follows revenue
Expense Quality
Inventory 15.9% vs COGS 12.4%. Normal
CapEx growth 249.0% is >2x revenue growth 13.6%
SG&A/Gross Profit = 79.7%, exceeds 70%
Gross margin 64.4%, change +0.4pp. Stable
Cash Flow Quality
CFFO/NI = 4.08. Profits backed by cash
FCF $0.0B, FCF/NI = 0.09
Accruals ratio = -3.4%. Low accruals
Cash $0.1B covers only 25% of debt $0.3B
Balance Sheet Health
Goodwill+Intangibles $0.4B = 92% of equity. Over 50%
Debt/EBITDA = 4.0x (>4x). Interest coverage = 1.0x (<2x). Financial stress
Other assets -37.8% vs revenue 13.6%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 3% YoY. Normal
Manipulation Score
M-Score = -2.46 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor AORT continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25